July 22, 2025 Join Global Leaders in Shaping the Future of Drug Development at C-Path’s 2025 Global Impact Conference Stakeholders across the life sciences ecosystem are invited to attend the 2025 C-Path's Global Impact Conference (CGIC), taking...
July 16, 2025 Critical Path Institute Appoints Dr. Aoife Brennan to Board of Directors C-Path today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings...
July 16, 2025 C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $200,000 grant to Carlos Subauste, M.D....
July 15, 2025 Preventing, Delaying Type 1 Diabetes Critical Path Institute, which formed the T1D Consortium in 2017, is working to accelerate the process to new therapies...
July 14, 2025 Principles of good practice for concept definition in the context of translation and linguistic validation of clinical outcome assessments (COAs) Translation teams conducting translation and cultural adaptation find it paramount to properly describe concepts of items...
July 9, 2025 C-Path’s Kristen Swingle Named a “Woman Leading the Region” by BizTucson C-Path) is proud to announce that President and Chief Operating Officer Kristen Swingle, M.S., has been named a 2025 BizTucson..
July 9, 2025 Celebrating 20 Years of Impact: C-Path Featured in Special BizTucson Anniversary Issue This year, C-Path proudly marks 20 years of advancing regulatory science and reshaping how new treatments are developed...
June 26, 2025 C-Path Q2 2025 Newsletter This year marks a historic milestone for C-Path as we celebrate 20 years of advancing regulatory science...
June 26, 2025 The Critical Path Institute Podcast: Connecting the Dots with DCC This newest Critical Path Institute® (C-Path) podcast episode provides an in-depth exploration of one of C-Path's core teams...
June 20, 2025 C-Path Launches Global Collaborative to Advance Drug Development for Neonatal Brain Injury C-Path, through its International Neonatal Consortium (INC), is proud to announce the official launch of the Neonatal Brain...